Tc(HSA17*N279K)1Mdk
Targeted Allele Detail
|
Symbol: |
Tc(HSA17*N279K)1Mdk |
Name: |
transchromosomal, human 17, line 1, Michael Koob; transchromosomal, human 17, line 1, Michael D Koob |
MGI ID: |
MGI:6705043 |
Synonyms: |
MAPT(H1.0*N279K)-GR |
Gene: |
Tc(HSA17*N279K)1Mdk Location: unknown Genetic Position: Chr11, Syntenic
|
Alliance: |
Tc(HSA17*N279K)1Mdk page
|
|
Germline Transmission: |
Earliest citation of germline transmission:
J:101977
|
Parent Cell Line: |
PRX-B6N (ES Cell)
|
Strain of Origin: |
C57BL/6NTac
|
|
Allele Type: |
|
Targeted (Humanized sequence, Inserted expressed sequence) |
Mutations: |
|
Insertion, Intergenic deletion, Nucleotide substitutions
|
|
|
Tc(HSA17*N279K)1Mdk expresses
2 genes
Knock-in expresses:
Organism |
Expressed Gene |
Homolog in Mouse |
Note |
human |
MAPT (4137) |
|
MAPT*N279K |
human |
SPPL2C (162540) |
|
|
|
|
|
Mutation details: A 157 kb deletion on mouse chromosome 11 stretching from, but not including, Crhr1 to Kansl1 is replaced by a syntenic 190 kb region from human chromosome 17 (HSA17). The mouse Sppl2c (signal peptide peptidase 2C) and Mapt (microtubule-associated protein tau) genes are replaced by human SPPL2C and MAPT (H1 haplotype) genes. The human MAPT gene was modified to include the N279K (asparaginine to lysine) mutation identified in FTD patients. A loxN-flanked neomycin resistance cassette that was removed by transient cre expression.
(J:101977)
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 1 strain available
Cell Lines: 0 lines available
|
Carrying any Tc(HSA17*N279K)1Mdk Mutation: |
1 strain or line available
|
|
Original: |
J:101977 The Jackson Laboratory, Information obtained from The Jackson Laboratory, Bar Harbor, ME. Unpublished. 2005-2017; |
All: |
1 reference(s) |
|